Navigation Links
Neuro-Oncology Pioneer Who Defined Standard of Care for Brain and Spinal Tumors Joins Capital Institute for Neurosciences
Date:12/4/2013

Hopewell Township, NJ (PRWEB) December 04, 2013

Dr. Roy Patchell, an internationally known leader in neuro-oncology, has joined Capital Institute for Neurosciences as Director of Neuro-Oncology, further elevating the Institute as a national leader in the area of neurosciences.

Dr. Patchell’s research has been instrumental in defining the treatments used for patients with brain and spinal tumors. He joins Dr. Arlan Mintz, Director of Neurosurgical Oncology, as part of the Institute’s National Brain Tumor Center. The center combines their significant experience with advanced technology and dedicated neuroscience resources offered in one convenient location at Capital Health.

“Dr. Patchell’s work has had a tremendous impact on the way brain and spinal tumors are treated,” said Dr. Erol Veznedaroglu, director of the Capital Institute for Neurosciences and chairman of the Department of Neurosurgery at Capital Health. “He is a perfect addition to the Institute’s team because I have no doubt his future work will be just as groundbreaking as the research he has already completed. His focus on pushing the boundaries of care forward is at the core of our mission to constantly seek better ways of treating patients with very serious brain and spine diseases.”

Over the past several years, Capital Health and its Capital Institute for Neurosciences have become known as a leader in providing the most state-of-the-art, subspecialty care available for complex conditions involving the brain. The number of healthcare facilities and physicians referring patients has grown significantly over the past five years elevating Capital Health to the leading position statewide for brain and aneurysm surgery. As a result, notable neuroscience experts from renowned programs around the county have chosen to join the Institute’s medical team.

Dr. Patchell’s research has been described as ‘transformative,’ and in two groundbreaking studies on brain tumors, he established the standard of care for these patients. In one study, Dr. Patchell and his colleagues conclusively demonstrated the benefits of surgical intervention. In a second study, he demonstrated the benefits of post-operative radiation therapy.

Dr. Patchell has also defined the standard of care for treating spinal cord compression caused by cancer demonstrating that surgical intervention, followed by radiation, is more effective than radiation alone.

Dr. Patchell joined Capital Health from the Barrow Neurological Institute in Phoenix, Arizona, where he was chairman of the Department of Neurology. Recognized as one of the top neurological institutes in the country, Dr. Patchell directed the institute’s Neurology Department, led its neuro-oncology program, and served on its Board of Directors. During his tenure, Dr. Patchell also oversaw the founding and opening of the Muhammad Ali Parkinson’s Center.

“My move to Capital Institute for Neurosciences allows me to be part of something incredibly unique. We are building something that will have a meaningful impact on how we treat patients with brain and spinal tumors,” said Dr. Patchell, who for more than 15 years has been recognized as one of America’s Top Doctors and America’s Top Doctors in Oncology.

“The Institute’s core mission of clinical excellence, research, and innovation extends beyond what one usually thinks of in a purely academic, university setting. The Institute does all of those things in a very community-focused, patient-centered way. You do not need to sacrifice personalized care to see the best doctors, and you can see specialists with very significant experience in a more comfortable and convenient setting.”

Prior to his tenure at Barrow, Dr. Patchell was the chief of Neuro-Oncology at the University of Kentucky Medical Center. He completed a neurology residency at Johns Hopkins University, a fellowship in neurology at New York Hospital-Cornell Medical Center, and a fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center.

Often invited to lecture around the country and internationally, Dr. Patchell has published extensively, including papers in The New England Journal of Medicine, The Journal of the American Medical Association, and The Lancet, among many others. Dr. Patchell has received substantial research funding from the National Institutes of Health, the National Cancer Institute, and the National Institute of Neurological Disorders and Stroke.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11393632.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. John Theurer Cancer Center brings leading experts for its Ninth Annual Neuro-Oncology Symposium
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. The Economist honors cancer immunotherapy pioneer James Allison
4. WesternU’s A Tribute to Caring Gala to Honor Health Care Pioneers
5. Pioneer in schizophrenia and ethics research receives Institute of Medicines 2013 Sarnat Prize
6. Brain Research Labs Brain Health And Performance News: Pioneer in the Field of Cognitive Performance and Health Succeeds with Clinically-Tested Natural Solutions
7. Pioneering Death-Care Educator Speaks about Honoring Life's Final Passage: Families Caring for Their Own at Death
8. Seva Call Launch to Navigate Virtual World for Pioneering Omahans
9. WebTeam Corporation Pioneers Entrepreneurship Program for High-Functioning Individuals on the Autism Spectrum
10. Daily QiGong and Chinese Medicine Improves Health Says Alternative Medicine Pioneer
11. Global Pioneers in Patient Advocacy, Regulation and Research to Speak at DIA Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Tampa, Fla. (PRWEB) , ... February 22, 2017 ... ... the field of regenerative medicine in recent years. The technology is so cutting ... sanction regulations on the protocol for stem cell procedures. However, successful patient outcomes ...
(Date:2/22/2017)... ... 2017 , ... Giving patients with diabetes customized coaching sessions, ... hospital admissions, and better blood pressure and glycemic control, a new study ... be found here . , The study comes as health plans increasingly ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse ... host Tom Seay and his production crew. Tom Seay’s program “Best of America ... world. Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, ...
(Date:2/22/2017)... ... February 22, 2017 , ... The ... Insights to help small practices in Delaware, New Jersey, Pennsylvania and West Virginia ... Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). , This technical ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent of ... report that family members or friends have also commented about their poor hearing. ... wear hearing aids. One reason, suggested by 89 percent of American respondents, is ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Orthopedic and cardiac devices will ... demographic patterns lead to an increasing prevalence of ... exercise-related injuries, chronic back problems, heart valve replacement, ... The future of medical implants faces many uncertainties. ... and more: - What types of medical ...
(Date:2/23/2017)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... quarter and full year 2016 financial results on Thursday, March ... markets. Following the announcement, members of the management team ... results and provide a general corporate update at 4:30 p.m. ... obtained as follows: Thursday, March 2 1:30 ...
(Date:2/22/2017)... VIEW, Calif. , Feb. 22, 2017 ... that it will release financial results for the fourth ... Wednesday, March 8, 2017.  The Company,s management team will ... PT / 5:00 p.m. ET. Investors interested ... by dialing (844) 707-0665 for domestic callers or (703) ...
Breaking Medicine Technology: